Skip to main content
. 2016 Feb 1;9(2):34–41.

TABLE 2.

Adverse events experienced by more than one patient across all aerosol foam treatment groups

ADVERSE EVENT CAL/BD AEROSOL FOAM (n=100) CAL AEROSOLFOAM (n=99) BD AEROSOL FOAM (n=99)
Medication residue 0 2 3
Application-site pain 1 1 1
Hypersensitivity 1 1 0
Nasopharyngitis 0 1 1
Contusion 1 0 1
Vitamin D decreased 1 0 1
Bronchitis 0 0 2

BD=betamethasone dipropionate 0.064%; Cal=calcipotriene 0.005%